Role of Sildenafil in Severe COVID-19 Pneumonia in Infancy - A Case Series

Authors

  • Jayant Kumar Muduli Department of Paediatrics, I Q City Medical College and Hospital, Durgapur- 713206, West Bengal, India.
  • Meenakshi Mitra Department of Paediatrics, I Q City Medical College and Hospital, Durgapur- 713206, West Bengal, India.
  • Asish Banerjee Department of Paediatrics, I Q City Medical College and Hospital, Durgapur- 713206, West Bengal, India.
  • Arnab Paul Department of Paediatrics, I Q City Medical College and Hospital, Durgapur- 713206, West Bengal, India.

DOI:

https://doi.org/10.3126/jnps.v42i1.41095

Keywords:

COVID-19 pneumonia in Infancy, Pulmonary Arterial Hypertension, Sildenafil

Abstract

SARS-CoV-2 virus primarily affects the respiratory system, although other organ systems are also involved. Though pulmonary arterial hypertension (PAH) has been described in as a sequela of COVID pneumonia in adults, only a coincidental association between pre-existing PAH and SARS-CoV-2 infection in children has been reported. To our knowledge, severe COVID pneumoniacausing PAH in children, especially in infancy has not been reported yet. With the meteoric spread of the pandemic and rapid development of newer mutated variants, the timely discovery of new drugs is near impossible. The idea of repurposing existing drugs to treat COVID-19 is an attractive strategy, especially if they are already approved (for other indications) and have wellestablished safety profiles. Sildenafil specifically targets pulmonary vasodilation, endothelial function, and vascular remodelling. It hence has emerged as an effective first - line oral therapeutic agent for patients with symptomatic PAH in all age groups. We present a case series of four cases where Sildenafil has been repurposed for the treatment of PAH associated with severe COVID-19 pneumonia in infancy.

Downloads

Download data is not yet available.
Abstract
101
PDF
113

Downloads

Published

2022-11-27

How to Cite

Muduli, J. K. ., Mitra, M., Banerjee, A., & Paul, A. (2022). Role of Sildenafil in Severe COVID-19 Pneumonia in Infancy - A Case Series. Journal of Nepal Paediatric Society, 42(1), 140–143. https://doi.org/10.3126/jnps.v42i1.41095

Issue

Vol. 42 No. 1 (2022)

Section

Case Series

License

Copyright (c) 2022 Jayant Kumar Muduli, Meenakshi Mitra, Asish Banerjee, Arnab Paul

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).